Novartis, Dr. Reddy's Deal Ends Exelon MDL
Dr. Reddy's Laboraties Inc. and Novartis AG have ended the multidistrict litigation over dementia treatment Exelon, striking a settlement deal a month after defendants Sun Pharmaceuticals Industries Inc. and Watson Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article